Medical Expert
Teva Branded Pharmaceutical Products R&D LLC · Merz North America, Inc. · Merz Therapeutics GmbH
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Medical Expert as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:35 UTC. Showing 200 of 289. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07920211 · Two Trials to Evaluate TEV-53408 in Participants With Non-Segmental VitiligoTeva Branded Pharmaceutical Products R&D LLC · not yet recruiting · Vitiligo · study director
- N/ANCT07913100 · Real-World Impact of TV-44749 in Adults With SchizophreniaTeva Branded Pharmaceutical Products R&D LLC · not yet recruiting · Schizophrenia · study director
- N/ANCT07856797 · A Study to Confirm Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial FoldsMerz North America, Inc. · recruiting · Nasolabial Folds · study director
- N/ANCT07797790 · Real-world Patient Experiences With Inbrija®Merz Therapeutics GmbH · recruiting · Parkinson Disease (PD), Parkinson's Disease, Off Episodes of Parkinson Disease · study director
- Ph1NCT07674940 · A Trial to Assess TEV-56286 at Different Doses in Healthy ParticipantsTeva Branded Pharmaceutical Products R&D LLC · recruiting · Healthy Volunteers · study director
- N/ANCT07614997 · Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and NeckMerz North America, Inc. · recruiting · Cutis Laxa · study director
- Ph4NCT07601516 · Real World Effectiveness and Safety of Deutetrabenazine in Adult Chinese Participants With Huntington's Disease (HD) Chorea in ChinaTeva Branded Pharmaceutical Products R&D LLC · completed · Huntington's Disease, Chorea · study director
- Ph3NCT07335588 · A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen SclerosusLEO Pharma · recruiting · Lichen Sclerosus · study director
- Ph3NCT07210463 · A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)Merz Aesthetics GmbH · active not recruiting · Neuromuscular Agents, Peripheral Nervous System Agents, Physiological Effects of Drugs · study director
- Ph2NCT07197866 · An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System AtrophyTeva Branded Pharmaceutical Products R&D LLC · recruiting · Multiple System Atrophy · study director
- Ph3NCT07122193 · A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United StatesMerz North America, Inc. · active not recruiting · Neuromuscular Agents, Peripheral Nervous System Agents, Physiological Effects of Drugs · study director
- N/ANCT07086248 · A Study to Determine if RADIESSE® Dilute Treatment in Décolleté of Adult Women Affects Radiographic Imaging AssessmentsMerz North America, Inc. · active not recruiting · Décolleté Wrinkles · study director
- Ph3NCT07018700 · A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic MigraineMerz Therapeutics GmbH · active not recruiting · Episodic Migraine · study director
- Ph3NCT07018713 · A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic MigraineMerz Therapeutics GmbH · active not recruiting · Chronic Migraine · study director
- Ph2NCT07013201 · A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar PustulosisLEO Pharma · recruiting · Palmoplantar Pustulosis · study director
- Ph1NCT06911567 · A Study to Assess New Formulations of TEV-56286Teva Branded Pharmaceutical Products R&D LLC · completed · Healthy Participants · study director
- Ph2NCT06807463 · A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac DiseaseTeva Branded Pharmaceutical Products R&D LLC · active not recruiting · Celiac Disease · study director
- Ph3NCT06664619 · A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaTeva Branded Pharmaceutical Products R&D LLC · completed · Asthma · study director
- Ph1NCT06627231 · Mass Balance Clinical Trial With TEV-56286Teva Branded Pharmaceutical Products R&D, Inc. · completed · Healthy Participants · study director
- Ph3NCT06624670 · A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma GangrenosumLEO Pharma · recruiting · Pyoderma Gangrenosum · study director
- Ph1NCT06625177 · A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With VitiligoTeva Branded Pharmaceutical Products R&D LLC · recruiting · Vitiligo · study director
- Ph2NCT06568237 · A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System AtrophyTeva Branded Pharmaceutical Products R&D LLC · active not recruiting · Multiple System Atrophy · study director
- Ph1NCT06480552 · An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsTeva Branded Pharmaceutical Products R&D LLC · recruiting · Advanced Solid Tumors · study director
- Ph1NCT06444867 · A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968LEO Pharma · completed · Joint Pain, Gout Flares, Joint Inflammation · study director
- N/ANCT06381999 · Validity and Inter-rater Reliability for Early Recognition of Spasticity Using the Decision Tree ToolMerz Therapeutics GmbH · completed · Post-stroke Spasticity · study director
- Ph1NCT06319170 · Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective DisorderTeva Branded Pharmaceutical Products R&D LLC · completed · Schizophrenia, Schizoaffective Disorder · study director
- Ph1NCT06315283 · An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With SchizophreniaTeva Branded Pharmaceutical Products R&D LLC · completed · Schizophrenia · study director
- Ph3NCT06311682 · A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic DermatitisLEO Pharma · recruiting · Atopic Dermatitis · study director
- Ph1NCT06290102 · Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years OldTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph1NCT06253546 · Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With SchizophreniaTeva Branded Pharmaceutical Products R&D LLC · completed · Schizophrenia · study director
- Ph2NCT06091020 · A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve InjuryMerz Therapeutics GmbH · completed · Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury · study director
- Ph3NCT06052267 · A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsTeva Branded Pharmaceutical Products R&D LLC · active not recruiting · Asthma · study director
- Ph4NCT06013969 · A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated FlaresLEO Pharma · completed · Generalized Pustular Psoriasis · study director
- Ph3NCT06004050 · A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand EczemaLEO Pharma · completed · Chronic Hand Eczema · study director
- Ph3NCT05958407 · A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic TherapyLEO Pharma · completed · Atopic Dermatitis, Atopic Hand Eczema · study director
- N/ANCT05943860 · Efficacy and Tolerability of Pantovigar® Vegan in Female Subjects With Diffuse Hair LossMerz Therapeutics GmbH · completed · Diffuse Hair Loss in Females · study director
- Ph2NCT05923099 · A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic DermatitisLEO Pharma · completed · Atopic Dermatitis · study director
- Ph3NCT05919082 · A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque PsoriasisLEO Pharma · completed · Stable Plaque Psoriasis · study director
- N/ANCT05884528 · Assessment of Long-term Clinical Response to BoNT in Cervical DystoniaMerz Therapeutics GmbH · completed · Cervical Dystonia · study director
- Ph1NCT05784363 · A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the FaceMerz North America, Inc. · completed · Enlarged Pores, Sebum Production · study director
- Ph2NCT05773053 · A Study of NT 201 Doses in the Treatment of Platysma ProminenceMerz Aesthetics GmbH · completed · Platysma Prominence · study director
- N/ANCT05773066 · A Study of Belotero® Intense Lidocaine for Lip AugmentationMerz North America, Inc. · completed · Lip Augmentation · study director
- Ph3NCT05693935 · A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With SchizophreniaTeva Branded Pharmaceutical Products R&D LLC · completed · Schizophrenia · study director
- Ph1NCT05682352 · Investigating the Safety of LEO 158968 in Healthy VolunteersLEO Pharma · completed · Healthy · study director
- Ph2NCT05668013 · A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseTeva Branded Pharmaceutical Products R&D LLC · active not recruiting · Crohn Disease, Colitis, Ulcerative · study director
- Ph1NCT05585398 · A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery MethodsMerz Pharmaceuticals GmbH · completed · N/A, as no Specific Medical Condition Will be Treated · study director
- Ph1NCT05508776 · A Trial to Evaluate the Effect of LEO 152020 on the Heart of Healthy PeopleJW Pharmaceutical · completed · Healthy Volunteers, Cardiac Repolarisation · study director
- Ph2NCT05499130 · A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseTeva Branded Pharmaceutical Products R&D, Inc. · completed · Crohn Disease, Colitis, Ulcerative · study director
- Ph1NCT05486117 · Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand EczemaLEO Pharma · completed · Chronic Hand Eczema · study director
- Ph2NCT05470114 · A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe ADLEO Pharma · completed · Atopic Dermatitis · study director
- Ph3NCT05458011 · A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With MigraineTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine · study director
- Ph2NCT05419908 · Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot FlashesOgeda S.A. · completed · Hot Flashes · study director
- Ph2NCT05388760 · Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)LEO Pharma · completed · Atopic Dermatitis · study director
- Ph3NCT05355818 · Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand EczemaLEO Pharma · completed · Chronic Hand Eczema · study director
- Ph3NCT05259722 · A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand EczemaLEO Pharma · completed · Chronic Hand Eczema · study director
- Ph3NCT05194540 · Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA)LEO Pharma · completed · Atopic Dermatitis · study director
- Ph2NCT05117060 · Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic DermatitisJW Pharmaceutical · completed · Atopic Dermatitis · study director
- Ph1NCT05099133 · A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese SubjectsLEO Pharma · completed · Atopic Dermatitis · study director
- N/ANCT05067504 · Effectiveness and Safety of the Octave System for Lifting the Eyebrow and Improving the Appearance of the Face and NeckMerz North America, Inc. · completed · Eyebrow Lift, Improved Appearance of the Face and Neck · study director
- Early Ph1NCT05050279 · A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy PeopleLEO Pharma · completed · Healthy · study director
- Ph3NCT04976192 · Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic UrticariaTeva Pharmaceuticals USA · completed · Chronic Urticaria · study director
- Ph3NCT04949841 · Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 TrialsLEO Pharma · completed · Chronic Hand Eczema · study director
- Ph2NCT04922021 · An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.LEO Pharma · completed · Atopic Dermatitis · study director
- N/ANCT04886232 · A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the CheekMerz North America, Inc. · completed · Cheek Volume Augmentation · study director
- Ph1NCT04883333 · A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy AdultsLEO Pharma · completed · Healthy · study director
- Ph3NCT04871711 · Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand EczemaLEO Pharma · completed · Chronic Hand Eczema · study director
- Ph3NCT04872101 · Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)LEO Pharma · completed · Chronic Hand Eczema · study director
- Ph2NCT04853992 · Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic UrticariaJW Pharmaceutical · completed · Cholinergic Urticaria · study director
- Ph2NCT04847674 · A Study to Test if TEV-53275 is Effective in Relieving AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Asthma · study director
- N/ANCT04795622 · Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and SubmentumMerz North America, Inc. · completed · Improvement in Skin Laxity of the Lower Face and Submentum · study director
- Ph2NCT04766723 · A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the ArmMerz Pharmaceuticals GmbH · completed · Essential Tremor of the Upper Limb · study director
- Ph3NCT04729621 · A Study to Test if TVB-009P is Effective in Relieving Postmenopausal OsteoporosisTeva Pharmaceuticals USA · completed · Osteoporosis, Postmenopausal · study director
- N/ANCT04681352 · A Study of Octave System for Improving Lines and Wrinkles of the DécolletéMerz North America, Inc. · completed · Décolleté Wrinkles · study director
- Ph1NCT04682353 · A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive AgeTeva Branded Pharmaceutical Products R&D, Inc. · completed · Contraception · study director
- Ph4NCT04677959 · A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph1NCT04674826 · A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy SubjectsLEO Pharma · completed · Healthy · study director
- N/ANCT04647721 · Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Moderate to Severe Nasolabial FoldsMerz North America, Inc. · completed · Correction of Moderate to Severe Nasolabial Folds (NLFs) · study director
- Ph3NCT04622254 · Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial LinesMerz North America, Inc. · completed · Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines) · study director
- N/ANCT04594239 · Evaluation of Effectiveness and Safety of Belotero Balance® (+) Lidocaine for Volume Augmentation of the Infraorbital HollowMerz North America, Inc. · completed · Volume Loss in the Infraorbital Hollow Area · study director
- Ph3NCT04594213 · Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial LinesMerz North America, Inc. · completed · Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines) · study director
- Ph3NCT04587453 · Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic DermatitisLEO Pharma · completed · Atopic Dermatitis · study director
- Ph2NCT04545385 · A Study to Test if TEV-48574 is Effective in Relieving AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Asthma · study director
- Ph4NCT04533737 · Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to UstekinumabLEO Pharma · terminated · Plaque Psoriasis, Psoriasis Vulgaris, Psoriasis · study director
- Ph3NCT04530110 · A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and AdolescentsTeva Branded Pharmaceutical Products R&D LLC · completed · Migraine · study director
- Ph3NCT04464707 · A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of AgeTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine · study director
- Ph3NCT04458857 · A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of AgeTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine · study director
- Ph2NCT04447729 · A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain SyndromeTeva Branded Pharmaceutical Products R&D, Inc. · withdrawn · Interstitial Cystitis · study director
- Ph1NCT04361136 · Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib CreamLEO Pharma · completed · Healthy · study director
- Ph3NCT04305327 · Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque PsoriasisLEO Pharma · terminated · Psoriasis · study director
- Ph4NCT04306315 · Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body WeightLEO Pharma · completed · Psoriasis Vulgaris · study director
- N/ANCT04210258 · Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the FaceMerz Pharmaceuticals GmbH · completed · Correction of Facial Wrinkles/Folds, Facial Volume Enhancement · study director
- Ph1NCT04203836 · A Trial to Evaluate the Effect of Food on LEO 152020JW Pharmaceutical · completed · Healthy · study director
- Ph3NCT04200352 · A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral PalsyTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Cerebral Palsy, Dyskinetic · study director
- N/ANCT04177212 · Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté WrinklesMerz Aesthetics GmbH · completed · Décolleté Wrinkles · study director
- Ph4NCT04041284 · A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive DisorderTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine, Major Depressive Disorder · study director
- Ph1NCT03995550 · Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single and Multiple Doses of LEO 142397 in Healthy People, Including JapaneseLEO Pharma · withdrawn · Healthy · study director
- Ph3NCT03992404 · Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain InjuryMerz Pharmaceuticals GmbH · active not recruiting · Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury · study director
- Ph3NCT03986424 · Local Study of Akatinol Memantine in VaD in RussiaMerz Pharmaceuticals GmbH · completed · Vascular Dementia · study director
- Ph2NCT03965091 · A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With FibromyalgiaTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Fibromyalgia · study director
- Ph2NCT03958955 · Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.LEO Pharma · terminated · Discoid Lupus Erythematosus · study director
- Ph1NCT03898583 · Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.LEO Pharma · completed · Psoriasis Vulgaris · study director
- Ph3NCT03893825 · A Study to Test if TV-46000 is Safe for Maintenance Treatment of SchizophreniaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Schizophrenia · study director
- Ph4NCT03890666 · A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph2NCT03886246 · Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous StudyLEO Pharma · active not recruiting · Generalized Pustular Psoriasis · study director
- Ph1NCT03826901 · Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and ChildrenLEO Pharma · completed · Atopic Dermatitis · study director
- Ph1NCT03812198 · A Trial to Investigate the Safety, Tolerability, and Drug Levels in Blood After Single and Multiple Doses of LEO 32731 in Healthy PeopleLEO Pharma · completed · Healthy · study director
- Ph3NCT03813238 · A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and AdolescentsTeva Branded Pharmaceutical Products R&D, Inc. · completed · Cerebral Palsy, Dyskinetic · study director
- Ph3NCT03806790 · Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis VulgarisLEO Pharma · completed · Psoriasis Vulgaris · study director
- Ph2NCT03806933 · Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown LinesMerz Aesthetics GmbH · completed · Moderate to Severe Glabellar Frown Lines · study director
- N/ANCT03777917 · A Pilot Study to Assess the Effectiveness and Safety of Belotero Balance® Injection for Volume Augmentation of the Infraorbital HollowMerz North America, Inc. · completed · Correction of Volume Loss in the Infraorbital Hollow Area · study director
- Ph3NCT03761537 · Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7LEO Pharma · completed · Atopic Dermatitis · study director
- Ph2NCT03725722 · Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.LEO Pharma · completed · Atopic Dermatitis · study director
- Ph4NCT03710044 · Investigation of Flare and Remission in Subjects With Atopic DermatitisLEO Pharma · withdrawn · Atopic Dermatitis · study director
- Ph1NCT03700658 · A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046Teva Branded Pharmaceutical Products R&D, Inc. · completed · Contraception · study director
- Ph2NCT03683719 · Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand EczemaLEO Pharma · completed · Chronic Hand Eczema · study director
- Ph1NCT03673527 · Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy SkinLEO Pharma · completed · Healthy · study director
- N/ANCT03650387 · Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the FaceMerz North America, Inc. · completed · Signs of Facial Aging With Volume Loss in the Upper Cheeks, Nasolabial Folds and Marionette Lines · study director
- N/ANCT03599349 · Evaluation of the Ulthera® System and Efficacy Correlation to Morphological DifferencesUlthera, Inc · completed · Facial and Neck Skin Laxity · study director
- Ph3NCT03587805 · Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTENDLEO Pharma · completed · Atopic Dermatitis · study director
- N/ANCT03583359 · Evaluation of Effectiveness and Safety of Radiesse (+) to Improve the Contour of Jawline by Adding Volume to the JawlineMerz North America, Inc. · completed · Improvement of Jawline Contour · study director
- Ph3NCT03571256 · A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)Teva Branded Pharmaceutical Products R&D, Inc. · completed · Tourette Syndrome · study director
- Ph3NCT03567291 · Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and AdolescentsTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Tourette Syndrome · study director
- Ph2NCT03562377 · Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)LEO Pharma · completed · Atopic Dermatitis · study director
- Ph1NCT03556592 · Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4LEO Pharma · completed · Atopic Dermatitis · study director
- N/ANCT03545412 · Clinical Study on the Application of a Non-Invasive Micro-Focused Ultrasound With Visualization System for Skin Laxity (ULT-215)Ulthera, Inc · completed · Facial Skin Laxity · study director
- Ph3NCT03526861 · Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).LEO Pharma · completed · Atopic Dermatitis · study director
- Ph3NCT03503318 · Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With SchizophreniaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Schizophrenia · study director
- Ph2/Ph3NCT03452943 · Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and AdolescentsTeva Branded Pharmaceutical Products R&D, Inc. · completed · Tourette Syndrome · study director
- Ph3NCT03363854 · Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3LEO Pharma · completed · Atopic Dermatitis · study director
- Ph2NCT03347188 · A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)Teva Branded Pharmaceutical Products R&D, Inc. · completed · Post-Traumatic Headache · study director
- Ph4NCT03331835 · A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque PsoriasisLEO Pharma · completed · Psoriasis Vulgaris · study director
- N/ANCT03320096 · Evaluation of the Ulthera System for Treating Axillary HyperhidrosisUlthera, Inc · completed · Axillary Hyperhidrosis · study director
- Ph3NCT03308968 · An Efficacy and Safety Study of Fremanezumab in Adults With MigraineTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine Prophylaxis · study director
- N/ANCT03282357 · Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Nasolabial Folds in ChinaMerz North America, Inc. · completed · Correction of the Moderate to Severe Nasolabial Folds · study director
- N/ANCT03256942 · Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume AugmentationMerz Pharmaceuticals GmbH · completed · Subjects Desiring Lip Augmentation · study director
- Ph3NCT03256695 · Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)Teva Branded Pharmaceutical Products R&D, Inc. · completed · Chronic Obstructive Pulmonary Disease · study director
- Ph3NCT03107052 · A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster HeadacheTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Cluster Headache · study director
- Ph3NCT03052725 · A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Eosinophils, Asthma · study director
- Ph3NCT03029000 · Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy ParticipantsTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Healthy Participants · study director
- Ph1NCT03019289 · A Study to Evaluate Sigma-1 and Dopamine-2 Receptor Occupancy by Pridopidine in the Human Brain of Healthy Volunteers and in Patients With Huntington's DiseasePrilenia · completed · Health Volunteers, Huntington Disease · study director
- Ph3NCT02980133 · Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder InhalerTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph3NCT02969408 · A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph3NCT02964338 · A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)Teva Branded Pharmaceutical Products R&D, Inc. · terminated · Chronic Cluster Headache · study director
- Ph3NCT02945046 · A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)Teva Branded Pharmaceutical Products R&D, Inc. · terminated · Episodic Cluster Headache · study director
- Ph4NCT02937168 · An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway InflammationTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Asthma · study director
- N/ANCT02904096 · Radiesse® Safety Study For the Treatment of HandsMerz North America, Inc. · completed · Volume Loss in the Dorsum of the Hand · study director
- N/ANCT02893241 · Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient SettingRatiopharm GmbH · completed · Hypotension · study director
- Ph1NCT02817464 · Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory CycleTeva Branded Pharmaceutical Products R&D, Inc. · completed · Pregnancy, Contraception · study director
- N/ANCT02809989 · A Study to Evaluate the Effect of Ovaleap® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap®-Pen.Teva Pharma GmbH · completed · Pregnancy Rate, Oocytes · study director
- Ph2NCT02769091 · A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 DiabetesTeva Branded Pharmaceutical Products R&D, Inc. · withdrawn · Nonalcoholic Steatohepatitis, Type 2 Diabetes Mellitus · study director
- Ph1NCT02684409 · Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute MigraineNuPathe Inc. · completed · Acute Migraine · study director
- Ph1NCT02680561 · A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph1NCT02674321 · A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)Auspex Pharmaceuticals, Inc. · completed · TOURETTE SYNDROME · study director
- Ph1NCT02673567 · To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125Teva Branded Pharmaceutical Products R&D, Inc. · completed · Pharmacokinetics · study director
- Ph3NCT02668692 · LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With PsoriasisLEO Pharma · completed · Psoriasis Vulgaris · study director
- Ph3NCT02638103 · Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of MigraineTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine · study director
- Ph3NCT02629861 · Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic MigraineTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine · study director
- Ph3NCT02621931 · Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic MigraineTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine · study director
- Ph1NCT02592031 · Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young WomenMerckle GmbH · completed · Bioequivalence · study director
- Ph3NCT02513160 · Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Persistent Asthma · study director
- Ph3NCT02501629 · An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood EosinophilsTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma, Elevated Blood Eosinophils, Oral Corticosteroid Dependence · study director
- Ph4NCT02499900 · Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®Teva Branded Pharmaceutical Products R&D, Inc. · completed · Multiple Sclerosis · study director
- Ph2NCT02494778 · A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's DiseasePrilenia · terminated · Huntington's Disease · study director
- Ph3NCT02487108 · Study to Evaluate the Analgesic Efficacy and Safety of Hydrocodone Bitartrate/Acetaminophen Immediate-Release Tablets in Participants With Moderate to Severe Pain Following BunionectomyTeva Branded Pharmaceutical Products R&D, Inc. · completed · Pain · study director
- Ph3NCT02452190 · Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood EosinophilsTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph1NCT02437604 · Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and OlderTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- N/ANCT02419872 · Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary DiseaseTeva Pharmaceuticals Europe · completed · Asthma, Chronic Obstructive Pulmonary Disease · study director
- N/ANCT02416076 · Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines TransducersUlthera, Inc · completed · Skin Laxity · study director
- Ph3NCT02410343 · Study of TV-1106 in Growth Hormone-Deficient AdultsTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Growth Hormone Deficiency · study director
- Ph3NCT02410356 · Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)Teva Branded Pharmaceutical Products R&D, Inc. · terminated · Growth Hormone Deficiency · study director
- N/ANCT02384512 · Azilect® In Wearing-Off (AIWO)Teva Pharma GmbH · completed · Parkinson's Disease · study director
- N/ANCT02384577 · Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD TreatmentTeva Pharma GmbH · completed · Patient Satisfaction · study director
- Ph2NCT02365636 · A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)Teva Branded Pharmaceutical Products R&D, Inc. · completed · Postherpetic Neuralgia · study director
- Ph1NCT02315144 · An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD PatientsTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Chronic Obstructive Pulmonary Disease · study director
- Ph1NCT02315131 · Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017Teva Branded Pharmaceutical Products R&D, Inc. · terminated · Chronic Obstructive Pulmonary Disease (COPD · study director
- Ph1NCT02306915 · PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian ParticipantsMerckle GmbH · completed · Pharmacokinetics, Pharmacodynamics · study director
- Ph3NCT02291861 · Addressing Involuntary Movements in Tardive DyskinesiaAuspex Pharmaceuticals, Inc. · completed · Tardive Dyskinesia · study director
- Ph2NCT02284568 · A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to PlaceboTeva Branded Pharmaceutical Products R&D, Inc. · completed · Primary Progressive Multiple Sclerosis · study director
- Ph3NCT02270736 · Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual DisabilityMerz Pharmaceuticals GmbH · completed · Chronic Troublesome Sialorrhea, Cerebral Palsy, Stroke · study director
- Ph1NCT02215941 · Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy VolunteersTeva Branded Pharmaceutical Products R&D, Inc. · completed · Pharmacokinetics · study director
- Ph2NCT02207946 · Botulinum Toxin A to Treat Arm TremorMerz Pharmaceuticals GmbH · completed · Essential Tremor of the Upper Limbs · study director
- Ph2NCT02203474 · A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary DiseaseTeva Branded Pharmaceutical Products R&D, Inc. · withdrawn · Chronic Obstructive Pulmonary Disease, COPD · study director
- Ph1NCT02202005 · Multiple Dose BE Study With Nevirapine 400mg PR TabletsRatiopharm GmbH · completed · HIV-1 · principal investigator
- Ph3NCT02198794 · Reducing Involuntary Movements in Participants With Tardive DyskinesiaAuspex Pharmaceuticals, Inc. · completed · Tardive Dyskinesia · study director
- Ph2/Ph3NCT02195700 · Aim to Reduce Movements in Tardive DyskinesiaAuspex Pharmaceuticals, Inc. · completed · Tardive Dyskinesia · study director
- Ph2NCT02190721 · A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow InvolvementTeva Branded Pharmaceutical Products R&D, Inc. · completed · Neutropenia · study director
- Ph2NCT02188277 · Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral PalsyMerz Pharmaceuticals GmbH · completed · Cerebral Palsy, Spastic Paraplegia and Hemiparesis, Equine and Equinovarus Foot Deformation · study director
- Ph1NCT02184767 · Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic MedicationTeva Branded Pharmaceutical Products R&D, Inc. · completed · BiPolar · study director
- Ph3NCT02175771 · Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Persistent Asthma · study director
- Ph3NCT02141854 · Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph3NCT02139644 · Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph3NCT02126839 · A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric AsthmaticsTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph1NCT02092571 · A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal WomenTeva Branded Pharmaceutical Products R&D, Inc. · completed · Pharmacokinetics · study director
- Ph3NCT02091739 · Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological ConditionsMerz Pharmaceuticals GmbH · completed · Chronic Troublesome Sialorrhea, Parkinson's Disease, Post-stroke · study director
- Ph1NCT02085863 · A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive When Both Treatments Are Given TogetherTeva Branded Pharmaceutical Products R&D, Inc. · completed · Pharmacokinetics, Pharmacodynamics · study director
- Ph1/Ph2NCT02078960 · A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)Teva Branded Pharmaceutical Products R&D, Inc. · terminated · Chronic Myeloid Leukemia · study director
- Ph3NCT02062463 · Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph3NCT02044276 · A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced NeutropeniaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia · study director
- Ph3NCT02040766 · A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph3NCT02031640 · A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:35 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed
- 3 citationsRCR 3.2